Skip to contents

A data frame of 2,279 individuals with blood cancer who have undergone a transplant. This data is identical to the ebmt4 data, except two extra variables have been derived, time until censoring and a censoring indicator, which are required to assess calibration using some of the methods in calibmsm. Code for the derivation of this dataset is provided in the source code for the package.

Usage

ebmtcal

Format

'ebmtcal'

A data frame with 2,279 rows and 17 columns:

id

Patient indentifier

rec, rec.s

Time until and event indicator for recovery variable

ae, ae.s

Time until and event indicator for adverse event variable

recae, recae.s

Time until and event indicator for recovery + adverse event variable

rel, rel.s

Time until and event indicator for relapse variable

srv, srv.s

Time until and event indicator for death variable

year

Year of transplant

agecl

Age at transplant

proph

Prophylaxis

match

Donor-recipient match

dtcens

Time of censoring

dtcens_s

Event indicator, 1:censoring occured, 0: absorbing state entered before censoring occured

Source

This dataset was derived from data made available within the mstate package, see ebmt4. The data was originally provided by the European Group for Blood and Marrow Transplantation (https://www.ebmt.org/). We reiterate the source statement given by the developers of mstate: "We acknowledge the European Society for Blood and Marrow Transplantation (EBMT) for making available these data. Disclaimer: these data were simplified for the purpose of illustration of the analysis of competing risks and multi-state models and do not reflect any real life situation. No clinical conclusions should be drawn from these data."

References

EBMT (2023). “Data from the European Society for Blood and Marrow Transplantation.” URL https://search.r-project.org/CRAN/refmans/mstate/html/EBMT-data.html.

de Wreede LC, Fiocco M, Putter H (2011). “mstate: An R Package for the Analysis of Competing Risks and Multi-State Models.” Journal of Statistical Software, 38(7).